Lurker Nancy (CIK 0001450485)

Latest company ownership

Shares held
1,152,531
Last filed at
Mar 9, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2009Q3 2025Q4
Shares held
342,736
Last filed at
Dec 5, 2025
Confidence Score
24.7
2025Q4
Confidence Score History
2017Q2 2025Q4
ALKS - Alkermes plc.
Role: Director
Shares held
8,013
Last filed at
Jun 2, 2025
Confidence Score
47.7
2025Q4
Confidence Score History
2025Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 4, 2025 Dec 5, 2025 EyePoint Pharmaceuticals, Inc. Director Sell 22.5 -9,300 -2.71% ✗ $140.5K
Nov 26, 2025 Dec 1, 2025 EyePoint Pharmaceuticals, Inc. Director Sell 43.8 -700 -0.20% ✗ $10.5K
May 31, 2025 Jun 2, 2025 Alkermes plc. Director Sell 22.5 -1,924 -15.23% ✗ $58.9K
Apr 11, 2025 Apr 14, 2025 Alkermes plc. Director Sell 26.3 -1,459 -18.61% ✗ $39.4K
Aug 16, 2024 Aug 20, 2024 EyePoint Pharmaceuticals, Inc. Director Buy 78.8 +3,173 1.43% ✗ $25K
Feb 9, 2024 Feb 13, 2024 EyePoint Pharmaceuticals, Inc. Chair Sell 40.0 -14,943 -6.64% ✗ $430.4K
Jan 23, 2024 Jan 25, 2024 EyePoint Pharmaceuticals, Inc. Chair Sell 20.0 -35,000 -15.72% ✗ $874.2K
Jan 6, 2024 Jan 9, 2024 EyePoint Pharmaceuticals, Inc. Chair Sell 40.0 -23,043 -11.91% ✗ $470.1K
Dec 4, 2023 Dec 6, 2023 EyePoint Pharmaceuticals, Inc. Chair Sell 20.0 -20,000 -10.50% ✗ $415.2K
Nov 15, 2021 Nov 17, 2021 EyePoint Pharmaceuticals, Inc. CEO Sell 28.8 -10,000 -8.81% ✓ $201.5K
Mar 10, 2020 Mar 11, 2020 EyePoint Pharmaceuticals, Inc. CEO Buy 95.0 +98,000 20.55% ✗ $104K
Oct 12, 2019 Oct 15, 2019 EyePoint Pharmaceuticals, Inc. CEO Sell 46.3 -10,745 -3.30% ✗ $22.6K
Mar 29, 2019 Apr 1, 2019 EyePoint Pharmaceuticals, Inc. CEO Buy 95.0 +28,500 13.46% ✗ $50.2K
Jun 14, 2017 Jun 14, 2017 EyePoint Pharmaceuticals, Inc. CEO Buy 95.0 +56,700 100.00% ✗ $100K
Nov 7, 2014 Nov 12, 2014 INTERPACE BIOSCIENCES, INC. CEO Buy 90.0 +49,000 5.06% ✗ $85.6K
Nov 5, 2014 Nov 7, 2014 INTERPACE BIOSCIENCES, INC. CEO Buy 87.5 +57,000 3.09% ✗ $99.1K
Mar 25, 2014 Mar 27, 2014 INTERPACE BIOSCIENCES, INC. CEO Sell 42.5 -23,316 -2.55% ✗ $114.5K
Mar 1, 2013 Mar 5, 2013 INTERPACE BIOSCIENCES, INC. CEO Sell 42.5 -16,279 -2.34% ✗ $121K
Aug 17, 2009 Aug 18, 2009 INTERPACE BIOSCIENCES, INC. CEO Buy 87.5 +9,960 3.56% ✗ $51K